One Chinese investment to resist

China’s seemingly unstoppable momentum certainly gets investors’ pulses racing, but, says Tom Bulford, not every company operating in China is worth a punt – and one especially is worth avoiding.

Here is a story about China told to me by Philip Connor. Philip was in Harbin, a Chinese city up near the border with Russia. He was in a taxi and asked to be taken to the City Hall. Expecting it to be slap in the middle of town, he was surprised when the taxi left the city and began to pass through bumpy country roads.

'Are you sure we are on the right road?' he asked the driver. 'Yes,' came the reply. 'Look.' And there looming up in the distance was a vast and gleaming building, the Chinese equivalent of a French chateau. Once inside this edifice, he ventured to enquire why it was built ten miles outside the city. 'Because,' came the reply, 'the city will come to us in just a few years' time the city will have grown and spread all around us.'

Subscribe to MoneyWeek

Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Get 6 issues free
https://cdn.mos.cms.futurecdn.net/flexiimages/mw70aro6gl1676370748.jpg

Sign up to Money Morning

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Sign up

Tom worked as a fund manager in the City of London and in Hong Kong for over 20 years. As a director with Schroder Investment Management International he was responsible for £2 billion of foreign clients' money, and launched what became Argentina's largest mutual fund. Now working from his home in Oxfordshire, Tom Bulford helps private investors with his premium tipping newsletter, Red Hot Biotech Alert.